Antagonists for treatment of cd11/cd18 adhesion receptor...

Details Antagonists for treatment of cd11/cd18 adhesion receptor... Antagonists for treatment of cd11/cd18 adhesion receptor...

C - Chemistry, Metallurgy

07

D

C07D 333/40 (2006.01) A61K 31/381 (2006.01) A61K 31/63 (2006.01) A61P 11/06 (2006.01) A61P 29/00 (2006.01) A61P 37/06 (2006.01) C07C 235/84 (2006.01) C07C 237/22 (2006.01) C07C 237/42 (2006.01) C07C 271/22 (2006.01) C07C 271/28 (2006.01) C07C 275/28 (2006.01) C07C 275/42 (2006.01) C07C 311/46 (2006.01) C07D 207/34 (2006.01) C07D 209/08 (2006.01) C07D 209/20 (2006.01) C07D 277/54 (2006.01) C07D 307/54 (2006.01) C07D 333/34 (2006.01) C07D 409/12 (2006.01)

Patent

CA 2325986

Compounds of the general structure D-L-B-(AA), for example (A), that are useful for treating Mac-1 or LFA-1-mediated disorders such as inflammatory disorders, allergies, and autoimmune diseases are provided.

L'invention concerne des composés qui correspondent à la structure générale D-L-B-(AA), par exemple à la structure (A), et sont utiles pour traiter des troubles induits par LFA-1 ou Mac-1, tels que des troubles inflammatoires, des allergies et des maladies auto-immunes.

Affiliated with

Also associated with

Rating

Antagonists for treatment of cd11/cd18 adhesion receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antagonists for treatment of cd11/cd18 adhesion receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antagonists for treatment of cd11/cd18 adhesion receptor... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1369104